ABL1 and ovarian carcinoma: Therefore, we consider this analysis a preliminary screen of the cell cycle pathway and one which indicates modest evidence for association with disease risk for only one gene, ABL1. Additional examination of ABL1 rs2855192, and including other SNPs with suggestive discovery set results, is warranted in additional studies within the ovarian cancer consortium (Ramus et al, 2008).